Sanrai Med India Revenue and Competitors
Estimated Revenue & Valuation
- Sanrai Med India's estimated annual revenue is currently $20.3M per year.
- Sanrai Med India's estimated revenue per employee is $125,500
Employee Data
- Sanrai Med India has 162 Employees.
- Sanrai Med India grew their employee count by 7% last year.
Sanrai Med India Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $16.8M | 134 | -4% | N/A | N/A |
#2 | $14.2M | 113 | 3% | N/A | N/A |
#3 | $11M | 88 | 1% | N/A | N/A |
#4 | $32.9M | 262 | 8% | N/A | N/A |
#5 | $20.3M | 162 | 7% | N/A | N/A |
#6 | $9.3M | 74 | 1% | N/A | N/A |
#7 | $30M | 239 | 7% | N/A | N/A |
#8 | $37.4M | 298 | 45% | N/A | N/A |
#9 | $36.3M | 289 | 6% | N/A | N/A |
#10 | $17.6M | 140 | 5% | N/A | N/A |
What Is Sanrai Med India?
Sanrai Med India Pvt Ltd is into Sales of Home Health Care products, where in we import various respiratory products from USA, Australia and other locations. We sell these products to our customers viz doctors (pulmonologist/cardiologist etc.), hospitals, dealers and to the patients suffering from respiratory /diabetic diseases.
keywords:N/A
N/A
Total Funding
162
Number of Employees
$20.3M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanrai Med India News
Sanrai Med India was born from this gap. In 2006, co-founders Jaspreet and Amarpreet Rai were faced with a situation where Jaspreet's...
Sanrai Med India bullish on bringing 'Hospital Grade Care at Home' through innovative medical equipments. ANI | Updated: Apr 07, 2022 12:44 IST.
But that same regulatory and quality control framework does not yet exist in the Indian medical device manufacturing sector. While Sanrai Med...
Other Companies in Chandigarh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.9M | 168 | 11% | N/A |
#2 | N/A | 170 | 53% | N/A |
#3 | $26.8M | 177 | 19% | N/A |
#4 | $34.7M | 197 | 5% | N/A |
#5 | N/A | 205 | 13% | N/A |